HCID 50943608, compound → HCID 67266851, compound
Reaction equation
[CH:1]1([C:4]2[NH:8][N:7]=[C:6]([NH:9][C:10]3[C:15]([Cl:16])=[CH:14][N:13]=[C:12]([C:17]4[S:21][C:20]([C@@H:22]([OH:24])[CH3:23])=[CH:19][CH:18]=4)[N:11]=3)[CH:5]=2)[CH2:3][CH2:2]1.C1(C2NN=C(NC3C(Cl)=CN=C(C4SC([C@H](O)C)=CC=4)N=3)C=2)CC1>>[CH:1]1([C:4]2[NH:8][N:7]=[C:6]([NH:9][C:10]3[C:15]([Cl:16])=[CH:14][N:13]=[C:12]([C:17]4[S:21][C:20]([CH:22]([OH:24])[CH3:23])=[CH:19][CH:18]=4)[N:11]=3)[CH:5]=2)[CH2:3][CH2:2]1Participants
3
Procedure
Following the 5-fluoro analogs, (S)-1-(5-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-chloropyrimidin-2-yl)thiophen-2-yl)ethanol (Compound 132) (4 mg) and (R)-1-(5-(4-(5-cyclopropyl-1H-pyrazol-3-ylamino)-5-chloropyrimidin-2-yl)thiophen-2-yl)ethanol (Compound 131) (3.7 mg) were prepared. Both had LC-MS: 362.1 [M+H]+.
Workup
- customwere prepared
Sources & evidence
- ORD record
- ord-eebd4210a0774939af9b1848253506b4
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09422271B2
Reaction notes
Loading…